About Hereditary Hemorrhagic Telangiectasia (HHT)

Overview

Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu disease, is a rare genetic vascular disorder. It is characterized by the development of multiple abnormal connections between arteries and veins, known as arteriovenous malformations (AVMs). These AVMs can occur in various organs, including the lungs, gastrointestinal tract, liver, and central nervous system. Additionally, HHT can cause recurrent nosebleeds (epistaxis) and the presence of small red markings on the skin called telangiectases. HHT is an autosomal dominant disorder, meaning that an affected individual has a 50% chance of passing the condition on to each of their children. Diagnosis of HHT is based on specific criteria, including recurrent nosebleeds, telangiectasias in characteristic locations, AVMs in internal organs, and a family history of HHT. Genetic mutations in genes such as ENG, ACVRL1, and SMAD4 are responsible for causing HHT.

Causes and Risk Factors

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant inherited disorder caused by mutations in genes involved in the transforming growth factor (TGF) signaling pathway, such as endoglin (ENG), activin A receptor type II-like 1 (ACVRL1 or ALK1), and SMAD4. These mutations lead to the development of abnormal blood vessels that are prone to rupture. Since this is an inherited condition, having a family history of the disease increases the risk of developing it.

It's important to consult with a healthcare professional for personalized advice and guidance regarding the management of HHT.

Symptoms

The most common early symptom of hereditary hemorrhagic elangiectasia (HHT) is recurrent nosebleeds, also known as epistaxis. These nosebleeds tend to increase in frequency and quantity as a person gets older. Other early symptoms may include telangiectases, which are red-purple spots that can appear on the face, lips, mucosa, and fingers.

As HHT progresses or becomes more severe, complications may occur. These include:

• Anemia: This is a common symptom in HHT patients due to bleeding from the telangiectases in the nasal mucosa or gastrointestinal tract.
• Gastrointestinal bleeding: Bleeding from telangiectases in the gastrointestinal tract can cause blood loss and lead to symptoms such as dark or bloody stool.
• Complications due to arteriovenous malformations (AVMs): AVMs are abnormal connections between arteries and veins that can occur in various organs, such as the lungs, brain, and liver. Complications from AVMs can range from mild to severe, depending on their location and size.

It's important to note that symptoms can vary widely among individuals with HHT. If you suspect you have HHT or are experiencing any concerning symptoms, it's best to consult with a healthcare professional for an accurate diagnosis and appropriate management.

Diagnosis

To diagnose hereditary hemorrhagic telangiectasia (HHT), the following examinations, tests, and procedures are commonly performed:

• Physical exam: The healthcare provider will look for physical signs of the condition, such as telangiectases on the face, lips, and fingers. They will ask about family and past medical history.
• Lab tests: Blood draws may be done to check for genetic changes, chromosomes, or proteins that are associated with HHT.
• Imaging studies: X-rays or MRIs may be recommended to visualize the affected areas and identify abnormalities.

To determine the stage or severity of HHT, additional examinations, tests, and procedures may include:

• Further lab tests: Additional blood tests may be ordered to assess specific markers related to HHT.
• Imaging studies: More advanced imaging techniques like CT scans or angiography may be used to evaluate blood vessels in detail.
• Specialized evaluations: Referral to specialists such as ophthalmologists or cardiologists may be necessary for a comprehensive assessment.

Remember that these recommendations can vary depending on individual cases. It's crucial to consult with your healthcare provider for personalized advice.

Treatment Options

The goals of treatment for hereditary hemorrhagic telangiectasia (HHT) are to manage symptoms, prevent complications, and improve quality of life. Here are the recommended treatments and how they work to achieve these goals:

Medications:

• Nasal sprays: These can help reduce nasal bleeding by constricting blood vessels in the nasal passages.
• Hormonal therapy: Certain hormonal medications may be prescribed to control bleeding episodes.
• Iron supplements: If anemia is present due to chronic bleeding, iron supplements may be recommended to restore iron levels.

Therapies:

• Laser therapy: Laser treatment can be used to cauterize or seal off abnormal blood vessels, reducing the risk of bleeding.
• Embolization: This procedure involves blocking abnormal blood vessels with a substance to prevent bleeding or redirect blood flow away from affected areas.
• Blood transfusions: In severe cases of bleeding or anemia, blood transfusions may be necessary to restore blood volume and improve oxygen delivery.

Health behavior changes:

• Avoiding triggers: Identifying and avoiding triggers that worsen symptoms, such as certain medications or activities, can help manage HHT.
• Nasal hygiene: Regular nasal irrigation and moisturizing can help keep the nasal passages moist and reduce the risk of nosebleeds.

It's important to note that treatment options may vary depending on the severity and location of HHT manifestations. Consulting with a healthcare professional is crucial for personalized treatment recommendations. Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Other side effects can occur. Check with your health care professional or read the information provided with your medication for additional side effect information.